RSS
|
Login
|
Register
HOME
SPECIALTY
Hematology-Oncology
Long Term Care
Nurse Practitioners
OB/GYN
Pharmacists
Physician Assistants
Primary Care Physicians
Residents
Urologists
THERAPEUTIC CATEGORIES
BRAND
GENERIC
COMPARE
NEWS
Drug News
Drugs in the Pipeline
Drug Safety Alerts and Recalls
New Drug Products
Polls & Surveys
Newsletters
News from Haymarket Journals
RESOURCES
Alerts (Sponsored)
Clinical Charts
Common Medical Abbreviations
Company
Drug Monograph Format
FDA Orange Book
Pharmacology Notes
Professional Associations
Video
Blogs
MPR Publications
Customer Service
Online Banner Ad Specs
Subscribe
DOWNLOAD
CME
JOBS
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Home
>
Therapeutic Categories
>
Central Nervous System
> Anxiety/OCD
Central Nervous System
»
Anxiety/OCD
Select All |
Compare
|
Add to Clipboard
|
View Clipboard
Name
Compare
Alprazolam INTENSOL
compare
ANAFRANIL
compare
ATIVAN
compare
BUSPAR
compare
CYMBALTA
compare
Diazepam injection
compare
Diazepam INTENSOL
compare
Diazepam oral solution
compare
EFFEXOR XR
compare
Fluvoxamine
compare
KLONOPIN
compare
KLONOPIN WAFERS
compare
LEXAPRO
compare
LEXAPRO ORAL SOLUTION
compare
LIBRIUM
compare
LIBRIUM INJECTABLE
compare
Lorazepam INTENSOL
compare
LUVOX CR
compare
NIRAVAM
compare
Oxazepam
compare
Oxazepam Tablets
compare
PAXIL
compare
PAXIL CR
compare
PAXIL SUSPENSION
compare
Prochlorperazine
compare
PROZAC
compare
PROZAC ORAL SOLUTION
compare
SINEQUAN
compare
SINEQUAN CONCENTRATE
compare
TRANXENE
compare
Trifluoperazine
compare
VALIUM
compare
VISTARIL
compare
VISTARIL SUSPENSION
compare
XANAX
compare
XANAX XR
compare
ZOLOFT
compare
ZOLOFT ORAL CONCENTRATE
compare
Most Popular
Most Emailed
Most Recent
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Trelstar 22.5mg approved for palliative treatment of prostate cancer
FDA halts marketing of unapproved nitroglycerin tablets
FDA accepts NDA for lurasidone, a treatment for schizophrenia
Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
Neosalus Cream available for dermatitis
Hibiclens General Skin Cleansing Patient Kit available
Bowel Cleansers
FDA warns of reduced Plavix efficacy in poor metabolizers
Silenor approved for insomnia
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Recommended Adult Immunization Schedule
Prevnar 13 pneumococcal disease vaccine approved
Neosalus Cream available for dermatitis
Xiaflex available for Dupuytren's contracture
Hizentra approved for primary immunodeficiency
Kapidex to be marketed under new trade name Dexilant
Ampyra available for multiple sclerosis patients
FDA grants priority review to Tasigna for newly diagnosed chronic myeloid leukemia
FDA accepts NDA for JZP-6, a treatment for fibromyalgia
Silenor approved for insomnia
The Medicines Company expands Cleviprex recall
FDA halts marketing of unapproved nitroglycerin tablets
Hibiclens General Skin Cleansing Patient Kit available
Bowel Cleansers
Neosalus Cream available for dermatitis
FDA warns of reduced Plavix efficacy in poor metabolizers
Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Trelstar 22.5mg approved for palliative treatment of prostate cancer
Sponsored Links